COR · XBRL financial data

Cencora financial statements, every fiscal year

The same tables from 8 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (COR's year ends in late September)

In millions of dollars	FY 2020Sep 30, 2020	FY 2021Sep 30, 2021	FY 2022Sep 30, 2022	FY 2023Sep 30, 2023	FY 2024Sep 30, 2024	FY 2025Sep 30, 2025
Revenue	189,894	213,989	238,587	262,173	293,959	321,333
Cost of goods and services sold	184,702	207,046	230,291	253,214	284,049	309,854
Gross profit	5,192	6,943	8,296	8,959	9,910	11,479
Selling, general and administrative	2,767	3,594	4,849	5,310	5,661	6,494
Total operating expenses	—	—	—	5,723	6,093	6,992
Operating income (loss)	(5,135)	2,354	2,366	2,341	2,175	2,629
Income tax expense (benefit)	(1,894)	677	517	428	485	691
Net income (loss)	(3,409)	1,540	1,699	1,745	1,509	1,554
Earnings per share, basic USD per share	(16.65)	7.48	8.15	8.62	7.60	8.02
Earnings per share, diluted USD per share	(16.65)	7.39	8.04	8.53	7.53	7.96
Weighted average shares, basic millions of shares	205	206	208	203	199	194
Weighted average shares, diluted millions of shares	205	208	211	205	200	195

Fiscal years (COR's year ends in late September)

In millions of dollars	FY 2020Sep 30, 2020	FY 2021Sep 30, 2021	FY 2022Sep 30, 2022	FY 2023Sep 30, 2023	FY 2024Sep 30, 2024	FY 2025Sep 30, 2025
Cash and cash equivalents	4,598	2,547	3,388	2,592	3,133	4,356
Accounts receivable	13,846	18,167	18,453	20,911	23,872	25,225
Inventory	12,589	15,368	15,556	17,455	18,999	20,492
Prepaid and other current assets	189	854	488	449	450	539
Total current assets	33,056	38,803	39,590	42,799	47,718	52,239
Property and equipment, net	1,485	2,163	2,135	2,135	2,181	2,539
Right-of-use asset	444	1,067	945	1,019	1,142	1,548
Goodwill	6,707	9,031	8,504	9,574	9,318	13,677
Total assets	44,275	57,338	56,561	62,559	67,102	76,590
Accounts payable	31,705	38,010	40,193	45,836	50,942	54,720
Accrued liabilities	1,647	2,856	2,215	2,354	2,759	2,983
Current portion of long-term debt	400	0	—	—	—	—
Total current liabilities	33,853	41,359	43,478	48,831	54,277	57,821
Long-term debt	3,618	6,384	4,632	4,146	3,812	7,543
Lease liability, non-current	386	946	864	924	1,030	1,417
Retained earnings	518	1,671	2,978	4,324	5,417	6,534
Total stockholders' equity	(1,019)	223	(212)	522	646	1,508
Total liabilities and equity	44,275	57,338	56,561	62,559	67,102	76,590
Common shares outstanding (cover page) millions of shares	204	208	206	201	193	194

Fiscal years (COR's year ends in late September)

In millions of dollars	FY 2020Sep 30, 2020	FY 2021Sep 30, 2021	FY 2022Sep 30, 2022	FY 2023Sep 30, 2023	FY 2024Sep 30, 2024	FY 2025Sep 30, 2025
Net income (loss)	(3,409)	1,540	1,699	1,745	1,509	1,554
Stock-based compensation	74	100	93	125	148	148
Depreciation and amortization	391	505	694	964	1,092	1,051
Net cash from operating activities	2,207	2,667	2,703	3,911	3,485	3,875
Purchases of property and equipment	370	438	496	458	487	668
Net cash from investing activities	(380)	(6,142)	(368)	(2,602)	(618)	(4,977)
Proceeds from issuing common stock	66	0	0	—	—	—
Share repurchases	420	82	484	1,181	1,491	435
Dividends paid	344	367	392	399	416	437
Repayments of long-term debt	598	835	—	811	663	1,281
Net cash from financing activities	(604)	1,953	(1,753)	(2,222)	(2,331)	2,249
Net change in cash	1,224	(1,528)	523	(841)	545	1,097

SIC 5122 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.

How peers are chosen

SIC 5122 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Fewer than three companies fall in that range, so the list adds same-SIC (5122) companies nearest in public float, each marked “added: same SIC”.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
Cencora	2,815	84,755	2,654*	190.8M	—	Q3 FY26 10-QJun 30, 2026
Cardinal Health	4,856	year only	year only	232.6M	—	Q4 FY26 10-KJun 30, 2026
McKesson	5,164	105,380	(220)	116.6M	—	Q1 FY27 10-QJun 30, 2026
Herbalifeadded: same SIC	409	1,350	151*	104.9M	—	Q3 FY26 10-QSep 30, 2026
Nu Skin Enterprisesadded: same SIC	190	320	11*	48.7M	—	Q2 FY26 10-QJun 30, 2026
DataMeds AIadded: same SIC	2.5	1.8	(2.9)*	3.1M	0.8 quarters	Q2 FY26 10-QJun 30, 2026
Cosmos Healthadded: same SIC	1.8	19	(1.7)*	100.6M	1.1 quarters	Q2 FY26 10-QJun 30, 2026
Stemtechadded: same SIC	0.2	0.6	(0.1)*	3.0B	4.5 quarters	Q2 FY26 10-QJun 30, 2026
HWH Internationaladded: same SIC	1.5	0.1	0.5*	7.7M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.